CorVel Appoints Sarah Scott as CEO
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 01 2026
0mins
CorVel announced that Sarah Scott will be appointed CEO and president, effective July 1, succeeding Michael Combs, who will transition to the role of executive chair. Combs has served as president since 2017 and CEO since 2019. As executive chair, Combs will, among other things, advise and support Scott during the leadership transition. Scott has served CorVel for more than 26 years and currently is the executive VP, product and corporate services.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CRVL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CRVL
About CRVL
CorVel Corporation applies technology, including artificial intelligence, machine learning and natural language processing, to enhance the management of episodes of care and the related health-care costs. The Company partners with employers, third-party administrators, insurance companies and government agencies to assist its customers in managing the medical costs of workers compensation, group health and auto insurance, and in monitoring the quality of care provided to claimants. Its services include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care and Medicare services. It delivers its solutions in three ways - as a fully integrated claims-management program, as discrete standalone services, or as targeted add-ons that enhance an existing client workflow. Integrated, end-to-end bundled programs are designed primarily for buyers such as self-insured employers who want a single, turnkey partner.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
CorVel Launches Market-Based Medical Bill Repricing Solution
- Innovative Bill Repricing: CorVel Corporation's newly launched Marketwise Repricing™ solution integrates market-based pricing methods to enhance cost containment in medical bill reviews, providing a more effective solution when traditional methods fall short.
- Increased Market Adaptability: By utilizing real-world reimbursement data, the solution ensures pricing outcomes better reflect local market conditions, particularly useful for out-of-network bills and in states with limited fee schedules, thereby enhancing clients' cost management capabilities.
- Seamless Workflow Integration: Marketwise Repricing integrates smoothly with existing bill review programs, ensuring end-to-end management while reducing administrative burdens, thus enhancing the effectiveness of existing strategies and offering alternatives for complex or high-variance billing scenarios.
- Strategic Implications: By delivering more supportable pricing outcomes, CorVel not only strengthens its competitive position in the medical bill management sector but also provides clients with more flexible cost control measures to adapt to the evolving landscape of healthcare expenses.
See More
CorVel Corporation Celebrates 35th Anniversary as a Public Company
- 35th Anniversary Celebration: CorVel Corporation will ring the Nasdaq opening bell in New York City on June 9, 2026, marking its 35th anniversary as a public company, highlighting its sustained influence and stability in the market.
- Strong Financial Performance: Fiscal year 2026 represents a pivotal moment for CorVel, as the company continues to achieve market momentum through technology investments and operational discipline, strengthening partnerships and boosting stakeholder confidence.
- Commitment to Long-Term Value: CEO Michael Combs stated that this milestone reflects the company's ongoing efforts in execution, investment, and market adaptability, indicating CorVel's dedication to long-term value creation in the years ahead.
- Technology-Driven Services: CorVel applies technologies such as artificial intelligence, machine learning, and natural language processing to enhance healthcare management efficiency, supporting partners like employers and insurance companies, showcasing its innovative capabilities in health and workers' compensation sectors.
See More
CorVel Appoints New CEO and President
- Executive Transition: CorVel announced that Sarah Scott will become CEO and President effective July 1, 2026, succeeding Michael Combs, who has served as President since 2017 and CEO since 2019, indicating a strategic leadership shift within the company.
- Leadership Experience: Scott has over 26 years of experience at CorVel and currently serves as Executive Vice President of Product and Corporate Services, which positions her well to leverage her extensive industry knowledge for future business growth.
- Growth and Development: Under Combs' leadership, CorVel has experienced significant growth and strategic development, reflecting the company's ongoing enhancement of its operational capabilities and market position.
- Future Outlook: The appointment of the new CEO signals CorVel's commitment to advancing its strategic objectives, particularly in launching large payer programs and transitioning towards prepaid solutions, which is expected to further strengthen the company's competitive edge.
See More
CorVel Appoints New CEO and President
- Leadership Transition: CorVel announced that Sarah Scott will become CEO and President effective July 1, 2026, succeeding Michael G. Combs, who has served as CEO since 2019 and will transition to Executive Chair, continuing to advance the company's long-term vision and strategic priorities.
- Successor's Background: With over 26 years at CorVel, Sarah Scott currently serves as Executive Vice President of Product and Corporate Services, where she has played a crucial role in enhancing operational performance, customer relationships, and strategic initiatives, underscoring her importance in the leadership transition.
- Board Support: Board member Jeff Michael stated that this leadership change reflects the strength of the leadership team and the company's long-term succession planning, emphasizing that Sarah is well-positioned to guide CorVel into its next growth phase.
- Future Outlook: Sarah Scott expressed her eagerness to lead CorVel, highlighting the exceptional team and culture in place, and her commitment to strengthening market leadership and delivering meaningful value for partners, team members, and shareholders, showcasing confidence in the company's future.
See More
Owls Nest Acquires Additional Shares in CorVel
- Share Acquisition: Owls Nest acquired 348,329 shares of CorVel in Q1 2026, with an estimated trade value of $20.06 million, indicating confidence in the company despite recent stock declines.
- AUM Growth: This transaction resulted in a 7.02% increase in Owls Nest's 13F reportable AUM, reflecting the effectiveness of its investment strategy in the healthcare management sector.
- Financial Performance: CorVel reported a 7% revenue increase to $959 million for fiscal 2026, with diluted earnings per share rising 17%, showcasing strong performance in the insurance and risk management space.
- Market Outlook: Growing demand for CorVel's healthcare payment accuracy platform, CERIS, is expected to provide greater revenue visibility, indicating that the company's strategic focus on innovation and operational efficiency is beginning to pay off.
See More
Owls Nest Partners Acquires New Position in CorVel
- New Position Disclosure: On May 14, 2026, Owls Nest Partners IA disclosed a new holding of 348,329 shares of CorVel (CRVL), with an estimated transaction value of $20.06 million, reflecting confidence in the company's potential.
- Asset Management Significance: CorVel now accounts for 6.66% of Owls Nest's reportable AUM, indicating its growing importance in the investment portfolio, which may influence future investment strategies.
- Financial Performance: CorVel's fiscal 2026 revenue rose by 7% to $959 million, while diluted earnings per share increased by 17% to $2.14, demonstrating the company's ability to grow even in challenging market conditions, attracting investor interest.
- Market Outlook: Despite a 45% decline in stock price, CorVel has secured several large clients for its healthcare payment accuracy platform, CERIS, which is expected to enhance future revenue visibility, underscoring the company's competitiveness in healthcare cost management.
See More
CorVel Launches Market-Based Medical Bill Repricing Solution
- Innovative Bill Repricing: CorVel Corporation's newly launched Marketwise Repricing™ solution integrates market-based pricing methods to enhance cost containment in medical bill reviews, providing a more effective solution when traditional methods fall short.
- Increased Market Adaptability: By utilizing real-world reimbursement data, the solution ensures pricing outcomes better reflect local market conditions, particularly useful for out-of-network bills and in states with limited fee schedules, thereby enhancing clients' cost management capabilities.
- Seamless Workflow Integration: Marketwise Repricing integrates smoothly with existing bill review programs, ensuring end-to-end management while reducing administrative burdens, thus enhancing the effectiveness of existing strategies and offering alternatives for complex or high-variance billing scenarios.
- Strategic Implications: By delivering more supportable pricing outcomes, CorVel not only strengthens its competitive position in the medical bill management sector but also provides clients with more flexible cost control measures to adapt to the evolving landscape of healthcare expenses.
See More
CorVel Corporation Celebrates 35th Anniversary as a Public Company
- 35th Anniversary Celebration: CorVel Corporation will ring the Nasdaq opening bell in New York City on June 9, 2026, marking its 35th anniversary as a public company, highlighting its sustained influence and stability in the market.
- Strong Financial Performance: Fiscal year 2026 represents a pivotal moment for CorVel, as the company continues to achieve market momentum through technology investments and operational discipline, strengthening partnerships and boosting stakeholder confidence.
- Commitment to Long-Term Value: CEO Michael Combs stated that this milestone reflects the company's ongoing efforts in execution, investment, and market adaptability, indicating CorVel's dedication to long-term value creation in the years ahead.
- Technology-Driven Services: CorVel applies technologies such as artificial intelligence, machine learning, and natural language processing to enhance healthcare management efficiency, supporting partners like employers and insurance companies, showcasing its innovative capabilities in health and workers' compensation sectors.
See More
CorVel Appoints New CEO and President
- Executive Transition: CorVel announced that Sarah Scott will become CEO and President effective July 1, 2026, succeeding Michael Combs, who has served as President since 2017 and CEO since 2019, indicating a strategic leadership shift within the company.
- Leadership Experience: Scott has over 26 years of experience at CorVel and currently serves as Executive Vice President of Product and Corporate Services, which positions her well to leverage her extensive industry knowledge for future business growth.
- Growth and Development: Under Combs' leadership, CorVel has experienced significant growth and strategic development, reflecting the company's ongoing enhancement of its operational capabilities and market position.
- Future Outlook: The appointment of the new CEO signals CorVel's commitment to advancing its strategic objectives, particularly in launching large payer programs and transitioning towards prepaid solutions, which is expected to further strengthen the company's competitive edge.
See More
CorVel Appoints New CEO and President
- Leadership Transition: CorVel announced that Sarah Scott will become CEO and President effective July 1, 2026, succeeding Michael G. Combs, who has served as CEO since 2019 and will transition to Executive Chair, continuing to advance the company's long-term vision and strategic priorities.
- Successor's Background: With over 26 years at CorVel, Sarah Scott currently serves as Executive Vice President of Product and Corporate Services, where she has played a crucial role in enhancing operational performance, customer relationships, and strategic initiatives, underscoring her importance in the leadership transition.
- Board Support: Board member Jeff Michael stated that this leadership change reflects the strength of the leadership team and the company's long-term succession planning, emphasizing that Sarah is well-positioned to guide CorVel into its next growth phase.
- Future Outlook: Sarah Scott expressed her eagerness to lead CorVel, highlighting the exceptional team and culture in place, and her commitment to strengthening market leadership and delivering meaningful value for partners, team members, and shareholders, showcasing confidence in the company's future.
See More
Owls Nest Acquires Additional Shares in CorVel
- Share Acquisition: Owls Nest acquired 348,329 shares of CorVel in Q1 2026, with an estimated trade value of $20.06 million, indicating confidence in the company despite recent stock declines.
- AUM Growth: This transaction resulted in a 7.02% increase in Owls Nest's 13F reportable AUM, reflecting the effectiveness of its investment strategy in the healthcare management sector.
- Financial Performance: CorVel reported a 7% revenue increase to $959 million for fiscal 2026, with diluted earnings per share rising 17%, showcasing strong performance in the insurance and risk management space.
- Market Outlook: Growing demand for CorVel's healthcare payment accuracy platform, CERIS, is expected to provide greater revenue visibility, indicating that the company's strategic focus on innovation and operational efficiency is beginning to pay off.
See More
Owls Nest Partners Acquires New Position in CorVel
- New Position Disclosure: On May 14, 2026, Owls Nest Partners IA disclosed a new holding of 348,329 shares of CorVel (CRVL), with an estimated transaction value of $20.06 million, reflecting confidence in the company's potential.
- Asset Management Significance: CorVel now accounts for 6.66% of Owls Nest's reportable AUM, indicating its growing importance in the investment portfolio, which may influence future investment strategies.
- Financial Performance: CorVel's fiscal 2026 revenue rose by 7% to $959 million, while diluted earnings per share increased by 17% to $2.14, demonstrating the company's ability to grow even in challenging market conditions, attracting investor interest.
- Market Outlook: Despite a 45% decline in stock price, CorVel has secured several large clients for its healthcare payment accuracy platform, CERIS, which is expected to enhance future revenue visibility, underscoring the company's competitiveness in healthcare cost management.
See More
